Redcliffe Labs

The Double Marker Test is a crucial prenatal screening recommended during the first trimester of pregnancy (11–14 weeks). It helps assess the risk of chromosomal abnormalities in the developing baby by measuring two key markers in the mother’s blood: free Beta-hCG and PAPP-A (Pregnancy-Associated Plasma Protein-A). Abnormal levels may indicate a higher probability of conditions such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), or Patau syndrome (Trisomy 13). Often combined with the NT (Nuchal Translucency) scan, this test provides greater accuracy in risk assessment. With Redcliffe Labs, expecting mothers can book the Double Marker Test at affordable prices, along with home sample collection, digital reports, and expert consultation, ensuring a safe and stress-free pregnancy journey.